Physiomics Plc (PYC):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA8012456)
◆英語タイトル:Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012456
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年12月5日
◆ページ数:49
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Physiomics Plc (PYC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects in exchange for product licenses and royalties. Its key services include designing optimal drug schedules, optimizing drug combinations, and single-blind validation study. The company is also involved in developing Virtual Tumour Clinical; cardiac tox prediction service; and drug combination database. Physiomics partners with small and large pharmaceutical and biotechnology companies which include Eli Lilly, Sareum, Cyclacel Pharmaceutical, Institute of Cancer Research, Cancer Research Technology, Bayer Technology Services GmbH and ValiRx. Physiomics is headquartered at Oxford, the UK.

Physiomics Plc Key Recent Developments

Nov 28,2017: Completion of VT Clinical Project with Merck and announcement of Master Services Agreement
Oct 16,2017: Physiomics: Final Results for the year ended 30 June 2017
Oct 02,2017: Physiomics: Company update 2017
Jul 31,2017: Physiomics announces Two new pre-clinical contracts
May 24,2017: Physiomics Provides Update on Two Further Extension Projects to Advance Oncology Candidate With Global Pharma Company

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Physiomics Plc – Key Facts 5
Physiomics Plc – Key Employees 6
Physiomics Plc – Key Employee Biographies 7
Physiomics Plc – Key Operational Employees 8
Physiomics Plc – Major Products and Services 9
Physiomics Plc – History 10
Physiomics Plc – Locations And Subsidiaries 13
Head Office 13
Section 2 – Company Analysis 14
Physiomics Plc – Business Description 14
Physiomics Plc – Corporate Strategy 15
Physiomics Plc – SWOT Analysis 16
SWOT Analysis – Overview 16
Physiomics Plc – Strengths 16
Physiomics Plc – Weaknesses 17
Physiomics Plc – Opportunities 18
Physiomics Plc – Threats 19
Physiomics Plc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Physiomics Plc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Nov 28, 2017: Completion of VT Clinical Project with Merck and announcement of Master Services Agreement 30
Oct 16, 2017: Physiomics: Final Results for the year ended 30 June 2017 31
Oct 02, 2017: Physiomics: Company update 2017 35
Jul 31, 2017: Physiomics announces Two new pre-clinical contracts 36
May 24, 2017: Physiomics Provides Update on Two Further Extension Projects to Advance Oncology Candidate With Global Pharma Company 37
Mar 24, 2017: Physiomics Announces Interim Results Statement for the six month period ended 31 December 2016 38
Jan 11, 2017: Physiomics: Company Update 40
Jan 06, 2017: Physiomics: Confirmation of Award of Innovate UK Grant 41
Oct 27, 2016: Physiomics: Final Results for the year ended 30 June 2016 42
Oct 25, 2016: Physiomics Announces Change of Director 44
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Physiomics Plc, Key Facts 5
Physiomics Plc, Key Employees 6
Physiomics Plc, Key Employee Biographies 7
Physiomics Plc, Key Operational Employees 8
Physiomics Plc, Major Products and Services 9
Physiomics Plc, History 10
Physiomics Plc, Key Competitors 20
Physiomics Plc, Ratios based on current share price 21
Physiomics Plc, Annual Ratios 22
Physiomics Plc, Annual Ratios (Cont...1) 23
Physiomics Plc, Interim Ratios 25
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Physiomics Plc, Recent Deals Summary 29
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Physiomics Plc (PYC):企業の財務・戦略的SWOT分析(Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆